Eupraxia Pharmaceuticals Q3 EPS $(0.23) Beats $(0.28) Estimate
Benzinga Newsdesk 4 hours ago
NewsEarningsEarnings Beats
Eupraxia Pharmaceuticals (NASDAQ:EPRX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.28) by 17.86 percent. This is a 21.05 percent decrease over losses of $(0.19) per
Eupraxia Pharmaceuticals (NASDAQ:EPRX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.28) by 17.86 percent. This is a 21.05 percent decrease over losses of $(0.19) per share from the same period last year.